Your browser doesn't support javascript.
loading
Avidity engineering of human heavy-chain-only antibodies mitigates neutralization resistance of SARS-CoV-2 variants.
Du, Wenjuan; Janssens, Rick; Mykytyn, Anna Z; Li, Wentao; Drabek, Dubravka; van Haperen, Rien; Chatziandreou, Marianthi; Rissmann, Melanie; van der Lee, Joline; van Dortmondt, Melissa; Martin, Itziar Serna; van Kuppeveld, Frank J M; Hurdiss, Daniel L; Haagmans, Bart L; Grosveld, Frank; Bosch, Berend-Jan.
Affiliation
  • Du W; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Janssens R; Department of Cell Biology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Mykytyn AZ; Harbour BioMed, Rotterdam, Netherlands.
  • Li W; Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands.
  • Drabek D; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • van Haperen R; Department of Cell Biology, Erasmus Medical Center, Rotterdam, Netherlands.
  • Chatziandreou M; Harbour BioMed, Rotterdam, Netherlands.
  • Rissmann M; Department of Cell Biology, Erasmus Medical Center, Rotterdam, Netherlands.
  • van der Lee J; Harbour BioMed, Rotterdam, Netherlands.
  • van Dortmondt M; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Martin IS; Department of Cell Biology, Erasmus Medical Center, Rotterdam, Netherlands.
  • van Kuppeveld FJM; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Hurdiss DL; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Haagmans BL; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Grosveld F; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Bosch BJ; Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
Front Immunol ; 14: 1111385, 2023.
Article in En | MEDLINE | ID: mdl-36895554
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: